期刊文献+

尿液中膀胱癌早期无创诊断的研究进展 被引量:2

下载PDF
导出
摘要 膀胱癌是泌尿系统最常见的肿瘤之一,其诊断及随访主要依赖于影像学、膀胱镜检查及活检和尿脱落细胞学检测。敏感性高、无创和简单易行是膀胱癌早期诊断和检测预后的准求目标,现将最新研究进展综述如下。
出处 《中国医药指南》 2013年第3期445-447,共3页 Guide of China Medicine
基金 科技攻关(20090112-4)
  • 相关文献

参考文献28

  • 1吴阶平.吴阶平泌尿外科学[M].济南:山东科学技术出版社,2003:1965-2973.
  • 2Jemal A,Siegel R,Xu J,et al.Cancer statistics,2010[J].CA Cancer J Clin,2010,60(5): 277-330.
  • 3Edwards BK,Ward E,Kohler BA,et al.Annual report to the nation on the status of cancer,1975-2006,featuring colorectal cancer trends and impact of interventions(risk factors,screening,and treatment) to reduce future rates[J].Cancer,2010,116(3): 544-573.
  • 4Jacobs BL,Lee CT, Montie JE.Bladder cancer.in 2010: how far have we come?[J].CA Cancer J Clin,2010,60(4): 244-272.
  • 5Cancer Facts and Figures,2004[M].Atlanta: American Cancer Society, Inc,2004.
  • 6那彦群,叶章群,孙光.中国泌尿外科疾病诊断治疗指南手册[S].北京:人民卫生出版社,2011:34-50.
  • 7Malkhasian KA,Petrov SV, Urianin M,et al.Use of fluoresent in situ hybridization in the cvtogenetic diagnosis of urinary bladder uroth- elial carcinoma[J].Vopr Onkol,2011,57(4): 462-469.
  • 8Xu C,Zeng Q,Hou J,Gao L,et al.Utility of a modality combining FISH and cytology in upper tract urothelial carcinoma detection in voided urine samples of Chinese patients[J].Urology,2011,77(3): 636-641.
  • 9Jia XY, Yu Q,Zhang ZH,Yang XF.Targeting bladder tumor cells in voided urine of Chinese patients with FITC-CSNRDARRC peptide ligand[J].Onco Targets Ther,2012,5: 85-90.
  • 10Proctor I,Stoeber K, Williams GH.Biomarkers in bladder cancer[J]. Histopathology,2010,57(1): 1-13.

共引文献29

同被引文献23

  • 1Liou LS. Urothelial cancer biomarkers for detection and surveil- lance [ J ]. Urology, 2006,67 ( 3 Suppl 1 ) :25-34.
  • 2Fernandez GJ, Garcia RJ, Escaf BS, et al. Urinary BTA-TRAK in the follow-up of superficial transitional-cell bladder carcinoma [ J ]. Arch Esp Urol, 2002,55 ( 1 ) :41-49.
  • 3Dey P. Urinary markers of bladder carcinoma[ J]. Clin Cbim Ac- ta, 2004,340( 1-2 ) :57-65.
  • 4Cai T, Mazzoli S, Meacci F, et al. Interleukin-6/10 ratio as a prog- nostic marker of recurrence in patients with intermediate risk urothe- lial bladder carcinoma[J]. J Urol, 2007,178(5) :1906-1911.
  • 5Siracusano S, Niceolini B, Knez R, et al. The simultaneous use of telomerasc, cytokeratin 20 and CD4 for bladder cancer detection in urine[J]. Eur Urol, 2005,47(3) :327-333.
  • 6Brown FM. Urine cytology. It is still the gold standard for screen- ing[ J]. Uml Clin North Am, 2000,27( 1 ) :25-37.
  • 7Wiener HG, Vooijs GP, Vant HB. Accuracy of urinary cytology in the diagnosis of primary and recurrent bladder cancer [ J ]. Acta Cytol, 1993,37 ( 2 ) : 163-169.
  • 8Sharma S, Dey P, Saikia UN, et al. Micronucleus scoring in urine cytology specimen by DNA-specific stain [ J ]. Anal Quant Cytol Histol, 2012,34( 1 ) :56-60.
  • 9Martinez-Pineiro JA, Muntanola P, Martin MG, et al. Fluores- cence urinary cytology in bladder cancer[ J ]. Eur Urol, 1977,3 (3) :142-144.
  • 10Zein TA, Milad MF. Urine cytology in bladder tumors [ J ]. Int Surg, 1991,76(1 ) :52-54.

引证文献2

二级引证文献17

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部